A critical advance in cancer study is occurring with the use of nanobodies to re-engage mutated p53. This vital malignant protector protein is frequently lost in several kinds of malignancies, resulting uncontrolled https://mediasocially.com/story6931285/mini-antibodies-revive-tumor-suppressor-p53-a-potential-pathway-for-malignant-therapy